State-of-the-Art Review: Low-Molecular Weight Heparin Prophylaxis in Surgical Patients

Abstract

Get full access to this article

View all access options for this article.

References

Collins R. , Scrimgeour A. , Yusuf S. , Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988;318: 1162-73.

Salzman E. , Davies GC Prophylaxis of venous thromboembolism. Analysis of cost-effectiveness. Ann Surg 1980;191:207-18.

Hull R. , Hksh J. , Sackett DL , Stoddart G. Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patie- uts. Can Med Assoc J 1982;127:990-5.

Bergqvist D. , Jendteg S. , Lindgren B. , Matzsch T. The economics of general thromboembolic prophylaxis . World J Surg 1988 ;12: 349-55.

Oster G. , Tuden RL , Colditz GA Prevention of venous thromboembolism after general surgery. Cost-effectiveness of alternative approaches to prophylaxis. Am J Med 1987;82:889-99.

Drummond M. , Aristides M. , Davies L. , Forbes, C. Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery. Br J Surg 1994;81: 1742-6.

Halkin H. , Goldberg J. , Modan M. , Modan B. Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med 1982;96:561-5.

Anderson FJ , Wheeler HB , Goldberg RJ , et al. A population-based perspective of the hospital incidence and case-fatality rates of venous thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med 1991;151:933-8.

Dalen J. , Alpert JS Natural history of pulmonary embolism. Prog Cardiovasc Dis 975;17:259-69.

10.

Bergqvist D. Lindblad, B. A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 1985;72:105-8.

11.

Nurmohamed M. , Rosendaal FS , Buller HR , Dekker E. Hommes DW , Vandenbroucke JP , Briet E. Low-molecular weight heparin versus standard heparin in general and orthopedic surgery: a meta-analysis. Lancet 1992;340:152-6.

12.

Jorgensen, LN , Wille-Jorgensen P. , Hauch, O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993;80:689-704.

13.

Leizorovicz, A. , Haugh, MC Cbapuis, FR , Samama, MM , Boissel, JP Low molecular weight heparin in prevention of perioperative thrombosis. Br Med J 1992 ;305:913-20.

14.

Mohr DN , Silverstein M. , Murtaugh PA , Harrison JM Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment. Arch Intern Med 1993;153:2221-8.

15.

Kakkar VV , Cohen AT , Edmonson RA , et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993;341:259-75.

16.

Hull R. , Raskob G. , Pineo G. , et al. A comparison of subcutaneous low-molecular weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993;329:1370-6.

17.

The RD Heparin Arthroplasty Group. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg (Am) 1994; 76:1174-85.

18.

Spiro TE , Fitzgerald RH , Trowbridge AA , et al. Enoxaparin a low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery [Abstract]. Blood 1994;84:246A.

19.

Heit J. , Berkowitz S. , Bona R. , et al. Efficacy and safety of normiflo (a LMWH) for prevention of venous thromboembolism following total knee replacement: a double-blind, dose-ranging study [Abstract]. Thromb Haemost 1995;73:978A.

20.

Leclerc JR , Geerts WH , Desjardins L. Laflamme, GH , et al. Prevention of venous thromboembolism after knee arthroplasty-A randomized, double-blind trial comparing enoxaparin to warfarin. Ann Intern Med 1996;124:619-26.